Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milano

Showing results (321-330 of 347) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing themJ L Lagrange, E Cassuto-Viguier, V Barbé, et al.
Oral Oncology|March 30, 2017
Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancerD Borchiellini, M C Etienne-Grimaldi, R J Bensadoun, et al.
Bulletin Du Cancer|September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]E Bardet, J Bourhis, L Cals, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
British Journal of Cancer|April 17, 1999
A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracilM C Etienne, X Pivot, J L Formento, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapyF-C Bidard, C Mathiot, A Degeorges, et al.
JACC. Cardiovascular Imaging|February 18, 2019
Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary ArteriesAmardeep Ghosh Dastidar, Anna Baritussio, Estefania De Garate, et al.
Cancer Biomarkers : Section a of Disease Markers|May 27, 2008
Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic valueA Tadlaoui Hbibi, C Lagorce, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patientsM-C Etienne-Grimaldi, S Pereira, N Magné, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancerG Milano, M-C Etienne-Grimaldi, L Dahan, et al.
Pageof 35

Showing results (321-330 of 347) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing themJ L Lagrange, E Cassuto-Viguier, V Barbé, et al.
Oral Oncology|March 30, 2017
Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancerD Borchiellini, M C Etienne-Grimaldi, R J Bensadoun, et al.
Bulletin Du Cancer|September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]E Bardet, J Bourhis, L Cals, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
British Journal of Cancer|April 17, 1999
A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracilM C Etienne, X Pivot, J L Formento, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapyF-C Bidard, C Mathiot, A Degeorges, et al.
JACC. Cardiovascular Imaging|February 18, 2019
Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary ArteriesAmardeep Ghosh Dastidar, Anna Baritussio, Estefania De Garate, et al.
Cancer Biomarkers : Section a of Disease Markers|May 27, 2008
Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic valueA Tadlaoui Hbibi, C Lagorce, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2005
Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patientsM-C Etienne-Grimaldi, S Pereira, N Magné, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancerG Milano, M-C Etienne-Grimaldi, L Dahan, et al.
Pageof 35